4-Fluoro-2-trifluoromethylbenzonitrile | CAS:194853-86-6

We serve 4-Fluoro-2-trifluoromethylbenzonitrile CAS:194853-86-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
4-Fluoro-2-trifluoromethylbenzonitrile

Chemical Name:4-Fluoro-2-trifluoromethylbenzonitrile
CAS.NO:194853-86-6
Synonyms:4-Fluoro-2-trifluoromethylbenzonitrile
4-fluoro-2-(trifluoromethyl)benzenecarbonitrile
4-cyano-(3-trifluoromethyl)fluorobenzene
 
Physical and Chemical Properties:
Density 1.4±0.1 g/cm3
Boiling Point 204.1±35.0 °C at 760 mmHg
Melting Point 43-45°C
Molecular Formula C8H3F4N
Molecular Weight 189.110
Flash Point 98.4±17.3 °C
Vapour Pressure 0.3±0.4 mmHg at 25°C
Index of Refraction 1.444
 
Specification:
Appearance:White to yellow crystals
Assay:≥98.0%
 
Packing:25 kg/drum, can also be packaged according to customer requirements
Storage:Store in a cool, ventilated place
Application:Intermediate of Organic synthesis.



Contact us for information like 4-Fluoro-2-trifluoromethylbenzonitrile chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,4-cyano-(3-trifluoromethyl)fluorobenzene physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,4-cyano-(3-trifluoromethyl)fluorobenzene Use and application,4-cyano-(3-trifluoromethyl)fluorobenzene technical grade,usp/ep/jp grade.


Related News: Among the APIs we produce, there is an API which passes through over ten kinds of intermediates in a process when it changes from being a raw material into an API.2-Butyl-3-(4-hydroxybenzoyl)benzofuran manufacturer In 2016, the export volume of China’s specialty drug substances reached US $ 3.53 billion, accounting for 13.8% of the total drug substances.2-Bromo-5-chloroanisole supplier Different cell types can be affected, although the most common finding in MDS is a shortage of red blood cells (anaemia). Patients with higher-risk MDS may progress to the development of acute leukaemia.methyl 2-bromo-3-[4-[2-(5-ethylpyridin-2-yl)ethoxy]phenyl]propanoate vendor Different cell types can be affected, although the most common finding in MDS is a shortage of red blood cells (anaemia). Patients with higher-risk MDS may progress to the development of acute leukaemia.The main API products include antihypertensive, psychotropic and anti-AIDS special APIs. Antihypertensive APIs are mainly pulic and sartan drugs, and they are the world’s major suppliers of pulic and sartan APIs.